<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Biopharmaceutical benchmarks 2014

Name: Biopharmaceutical benchmarks 2014
Creator: Gary Walsh
Keywords: 0301 basic medicine, 0303 health sciences, Biomedical Research, Drug Industry, Antibodies, Monoclonal, Genetic Therapy, United States, Biopharmaceutics, 3. Good health, Europe

descriptionPublicationkeyboard_double_arrow_right Article 01 Oct 2014 English Publisher:Springer Science and Business Media LLCJournal:Nature Biotechnology, volume 32, pages 992-1,000 (issn: 1087-0156, eissn: 1546-1696,

Authors: Gary Walsh;

doi: 10.1038/nbt.3040

pmid: 25299917

Biopharmaceutical benchmarks 2014

- Summary
- Subjects
- Metrics

Abstract

Monoclonal antibodies continue their march on the markets, optimized so-called biobetter versions of existing biologics are also gaining ground, but the rate of biosimilar approvals has seen a dramatic slowdown in recent years.

Related Organizations

University of Limerick
Ireland

Keywords

Biomedical Research, Drug Industry, Antibodies, Monoclonal, Genetic Therapy, United States, Biopharmaceutics, Europe, Mice, Animals, Humans, Biosimilar Pharmaceuticals, Drug Approval, Biotechnology

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	918
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 0.1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 0.01%